Why Is the New York Times Laundering the Reputation of a Sleazy AI Startup That’s Selling GLP-1s via a Dishonest Dumpster Fire of Fake Doctors, Phony Before-and-After Pictures, and Other Glaring Red Flags?

A New York Times profile praised Medvi as a fast-scaling AI-powered weight-loss startup with a very small team.

A prior investigation, however, alleged deceptive marketing: fake doctor endorsements, stolen or altered before-and-after photos, and misleading media logos.

The reporting also said Medvi used AI-generated ads and manipulated customer imagery to sell GLP-1 weight-loss drugs.

The dispute highlights the need for tougher scrutiny of AI health startups and consumer medical marketing.